Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
Identifieur interne : 007F20 ( Main/Exploration ); précédent : 007F19; suivant : 007F21Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
Auteurs : P. Vanamail [Inde] ; K D Ramaiah ; S. Subramanian ; S P Pani ; J. Yuvaraj ; P K DasSource :
- Annals of tropical medicine and parasitology [ 0003-4983 ] ; 2005.
Descripteurs français
- KwdFr :
- Animaux, Calendrier d'administration des médicaments, Diéthylcarbamazine (administration et posologie), Diéthylcarbamazine (effets indésirables), Filaricides (administration et posologie), Filaricides (effets indésirables), Filariose lymphatique (), Fièvre (), Humains, Inde, Ivermectine (administration et posologie), Ivermectine (effets indésirables), Loi du khi-deux, Nausée (), Observance thérapeutique, Population rurale, Services de médecine préventive, Wuchereria bancrofti, Études de cohortes, Évaluation de programme.
- MESH :
- administration et posologie : Diéthylcarbamazine, Filaricides, Ivermectine.
- effets indésirables : Diéthylcarbamazine, Filaricides, Ivermectine.
- Animaux, Calendrier d'administration des médicaments, Filariose lymphatique, Fièvre, Humains, Inde, Loi du khi-deux, Nausée, Observance thérapeutique, Population rurale, Services de médecine préventive, Wuchereria bancrofti, Études de cohortes, Évaluation de programme.
- Wicri :
- geographic : Inde.
English descriptors
- KwdEn :
- Animals, Chi-Square Distribution, Cohort Studies, Diethylcarbamazine (administration & dosage), Diethylcarbamazine (adverse effects), Drug Administration Schedule, Elephantiasis, Filarial (prevention & control), Fever (chemically induced), Filaricides (administration & dosage), Filaricides (adverse effects), Humans, India, Ivermectin (administration & dosage), Ivermectin (adverse effects), Nausea (chemically induced), Patient Compliance, Preventive Health Services, Program Evaluation, Rural Population, Wuchereria bancrofti.
- MESH :
- chemical , administration & dosage : Diethylcarbamazine, Filaricides, Ivermectin.
- chemical , adverse effects : Diethylcarbamazine, Filaricides, Ivermectin.
- geographic : India.
- chemically induced : Fever, Nausea.
- prevention & control : Elephantiasis, Filarial.
- Animals, Chi-Square Distribution, Cohort Studies, Drug Administration Schedule, Humans, Patient Compliance, Preventive Health Services, Program Evaluation, Rural Population, Wuchereria bancrofti.
Abstract
Current programmes to eliminate lymphatic filariasis (LF) are largely based on annual mass administrations of single doses of antifilarial drugs. The level and pattern of compliance by the target population are important determinants of the success of such mass drug administrations (MDA). Community compliance was therefore investigated during a study in southern India of the effects, on Wuchereria bancrofti microfilaraemia and transmission, of spaced MDA based on diethylcarbamazine (DEC) or ivermectin (IVM). During six rounds of MDA, the frequency of compliance in the target populations, in the five study villages given DEC and the five given IVM, ranged from 55%-77%. Analysis of the relevant cohort data indicated that about 30% of the villagers had complied with treatment during all six rounds, but 3.5% of those in the DEC arm and 4.0% of those in the IVM arm had never complied with treatment. Most of the villagers (>90%) had received treatment at least once, however, and >60% had each received treatment in at least four of the six rounds. Overall, there was a significant negative correlation (r=-0.78; P=0.008) between the size of the village, in terms of the number of villagers, and the mean frequency of compliance over the six rounds of MDA. The pattern of community compliance was found to be 'semi-systematic', laying between random and systematic. In terms of the elimination of LF, a semi-systematic pattern of compliance is worse than random compliance but better than systematic. The relevance of the levels and patterns of compliance to LF control or elimination is discussed.
DOI: 10.1179/136485905X29666
PubMed: 15829133
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003D08
- to stream PubMed, to step Curation: 003D08
- to stream PubMed, to step Checkpoint: 003D08
- to stream Ncbi, to step Merge: 001E00
- to stream Ncbi, to step Curation: 001E00
- to stream Ncbi, to step Checkpoint: 001E00
- to stream Main, to step Merge: 008129
- to stream Main, to step Curation: 007F20
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.</title><author><name sortKey="Vanamail, P" sort="Vanamail, P" uniqKey="Vanamail P" first="P" last="Vanamail">P. Vanamail</name><affiliation wicri:level="1"><nlm:affiliation>Vector Control Research Centre (Indian Council of Medical Research), Medical Complex, Indira Nagar, Pondicherry 605 006, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Vector Control Research Centre (Indian Council of Medical Research), Medical Complex, Indira Nagar, Pondicherry 605 006</wicri:regionArea><wicri:noRegion>Pondicherry 605 006</wicri:noRegion></affiliation></author><author><name sortKey="Ramaiah, K D" sort="Ramaiah, K D" uniqKey="Ramaiah K" first="K D" last="Ramaiah">K D Ramaiah</name></author><author><name sortKey="Subramanian, S" sort="Subramanian, S" uniqKey="Subramanian S" first="S" last="Subramanian">S. Subramanian</name></author><author><name sortKey="Pani, S P" sort="Pani, S P" uniqKey="Pani S" first="S P" last="Pani">S P Pani</name></author><author><name sortKey="Yuvaraj, J" sort="Yuvaraj, J" uniqKey="Yuvaraj J" first="J" last="Yuvaraj">J. Yuvaraj</name></author><author><name sortKey="Das, P K" sort="Das, P K" uniqKey="Das P" first="P K" last="Das">P K Das</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15829133</idno><idno type="pmid">15829133</idno><idno type="doi">10.1179/136485905X29666</idno><idno type="wicri:Area/PubMed/Corpus">003D08</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003D08</idno><idno type="wicri:Area/PubMed/Curation">003D08</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003D08</idno><idno type="wicri:Area/PubMed/Checkpoint">003D08</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003D08</idno><idno type="wicri:Area/Ncbi/Merge">001E00</idno><idno type="wicri:Area/Ncbi/Curation">001E00</idno><idno type="wicri:Area/Ncbi/Checkpoint">001E00</idno><idno type="wicri:doubleKey">0003-4983:2005:Vanamail P:pattern:of:community</idno><idno type="wicri:Area/Main/Merge">008129</idno><idno type="wicri:Area/Main/Curation">007F20</idno><idno type="wicri:Area/Main/Exploration">007F20</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.</title><author><name sortKey="Vanamail, P" sort="Vanamail, P" uniqKey="Vanamail P" first="P" last="Vanamail">P. Vanamail</name><affiliation wicri:level="1"><nlm:affiliation>Vector Control Research Centre (Indian Council of Medical Research), Medical Complex, Indira Nagar, Pondicherry 605 006, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Vector Control Research Centre (Indian Council of Medical Research), Medical Complex, Indira Nagar, Pondicherry 605 006</wicri:regionArea><wicri:noRegion>Pondicherry 605 006</wicri:noRegion></affiliation></author><author><name sortKey="Ramaiah, K D" sort="Ramaiah, K D" uniqKey="Ramaiah K" first="K D" last="Ramaiah">K D Ramaiah</name></author><author><name sortKey="Subramanian, S" sort="Subramanian, S" uniqKey="Subramanian S" first="S" last="Subramanian">S. Subramanian</name></author><author><name sortKey="Pani, S P" sort="Pani, S P" uniqKey="Pani S" first="S P" last="Pani">S P Pani</name></author><author><name sortKey="Yuvaraj, J" sort="Yuvaraj, J" uniqKey="Yuvaraj J" first="J" last="Yuvaraj">J. Yuvaraj</name></author><author><name sortKey="Das, P K" sort="Das, P K" uniqKey="Das P" first="P K" last="Das">P K Das</name></author></analytic><series><title level="j">Annals of tropical medicine and parasitology</title><idno type="ISSN">0003-4983</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Chi-Square Distribution</term><term>Cohort Studies</term><term>Diethylcarbamazine (administration & dosage)</term><term>Diethylcarbamazine (adverse effects)</term><term>Drug Administration Schedule</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Fever (chemically induced)</term><term>Filaricides (administration & dosage)</term><term>Filaricides (adverse effects)</term><term>Humans</term><term>India</term><term>Ivermectin (administration & dosage)</term><term>Ivermectin (adverse effects)</term><term>Nausea (chemically induced)</term><term>Patient Compliance</term><term>Preventive Health Services</term><term>Program Evaluation</term><term>Rural Population</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Calendrier d'administration des médicaments</term><term>Diéthylcarbamazine (administration et posologie)</term><term>Diéthylcarbamazine (effets indésirables)</term><term>Filaricides (administration et posologie)</term><term>Filaricides (effets indésirables)</term><term>Filariose lymphatique ()</term><term>Fièvre ()</term><term>Humains</term><term>Inde</term><term>Ivermectine (administration et posologie)</term><term>Ivermectine (effets indésirables)</term><term>Loi du khi-deux</term><term>Nausée ()</term><term>Observance thérapeutique</term><term>Population rurale</term><term>Services de médecine préventive</term><term>Wuchereria bancrofti</term><term>Études de cohortes</term><term>Évaluation de programme</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term><term>Ivermectin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term><term>Ivermectin</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>India</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Diéthylcarbamazine</term><term>Filaricides</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Fever</term><term>Nausea</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Diéthylcarbamazine</term><term>Filaricides</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Chi-Square Distribution</term><term>Cohort Studies</term><term>Drug Administration Schedule</term><term>Humans</term><term>Patient Compliance</term><term>Preventive Health Services</term><term>Program Evaluation</term><term>Rural Population</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Calendrier d'administration des médicaments</term><term>Filariose lymphatique</term><term>Fièvre</term><term>Humains</term><term>Inde</term><term>Loi du khi-deux</term><term>Nausée</term><term>Observance thérapeutique</term><term>Population rurale</term><term>Services de médecine préventive</term><term>Wuchereria bancrofti</term><term>Études de cohortes</term><term>Évaluation de programme</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Inde</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Current programmes to eliminate lymphatic filariasis (LF) are largely based on annual mass administrations of single doses of antifilarial drugs. The level and pattern of compliance by the target population are important determinants of the success of such mass drug administrations (MDA). Community compliance was therefore investigated during a study in southern India of the effects, on Wuchereria bancrofti microfilaraemia and transmission, of spaced MDA based on diethylcarbamazine (DEC) or ivermectin (IVM). During six rounds of MDA, the frequency of compliance in the target populations, in the five study villages given DEC and the five given IVM, ranged from 55%-77%. Analysis of the relevant cohort data indicated that about 30% of the villagers had complied with treatment during all six rounds, but 3.5% of those in the DEC arm and 4.0% of those in the IVM arm had never complied with treatment. Most of the villagers (>90%) had received treatment at least once, however, and >60% had each received treatment in at least four of the six rounds. Overall, there was a significant negative correlation (r=-0.78; P=0.008) between the size of the village, in terms of the number of villagers, and the mean frequency of compliance over the six rounds of MDA. The pattern of community compliance was found to be 'semi-systematic', laying between random and systematic. In terms of the elimination of LF, a semi-systematic pattern of compliance is worse than random compliance but better than systematic. The relevance of the levels and patterns of compliance to LF control or elimination is discussed.</div></front></TEI><affiliations><list><country><li>Inde</li></country></list><tree><noCountry><name sortKey="Das, P K" sort="Das, P K" uniqKey="Das P" first="P K" last="Das">P K Das</name><name sortKey="Pani, S P" sort="Pani, S P" uniqKey="Pani S" first="S P" last="Pani">S P Pani</name><name sortKey="Ramaiah, K D" sort="Ramaiah, K D" uniqKey="Ramaiah K" first="K D" last="Ramaiah">K D Ramaiah</name><name sortKey="Subramanian, S" sort="Subramanian, S" uniqKey="Subramanian S" first="S" last="Subramanian">S. Subramanian</name><name sortKey="Yuvaraj, J" sort="Yuvaraj, J" uniqKey="Yuvaraj J" first="J" last="Yuvaraj">J. Yuvaraj</name></noCountry><country name="Inde"><noRegion><name sortKey="Vanamail, P" sort="Vanamail, P" uniqKey="Vanamail P" first="P" last="Vanamail">P. Vanamail</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007F20 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007F20 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:15829133
|texte= Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15829133" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |